FOXM1 and hepatocellular carcinoma: Gusarova et al. [18] showed that inhibition of FOXM1 function by a cell-penetrating ARF (26–44) peptide lead to reduced tumour cell proliferation and angiogenesis in hepatocellular carcinoma.